Startups
2013
MOSAIC BIOMEDICALS SLDevelopes an antibody directed against LIF, a pleiotropic cytokine that is overexpressed in certain solid tumors
Company sold to Northern Biologics in 2016
Company sold to Northern Biologics in 2016
Address
Carrer de Baldiri Reixac 4-8, 08028 Barcelona, Spain
CERCA ownership
Barcelona, Spain
2006
Vall d’Hebron Institut d’Oncologia (VHIO)
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
CERCA Center Contact
MD
Mario De la Cuesta Rivero
Vall d’Hebron Institut d’Oncologia (VHIO)Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s immune system.
Mosaic’s innovative treatments are derived from a deep understanding of the tumor biology and aim to offer safer and more effective options to cancer patients.
Mosaic’s innovative treatments are derived from a deep understanding of the tumor biology and aim to offer safer and more effective options to cancer patients.
Product description
The compound that Mosaic Biomedicals develops is a first-in-class antibody directed against LIF, a pleiotropic cytokine that is overexpressed in certain solid tumors. LIF promotes cancer progression by regulating the microenvironment of the tumor and tumor-initiating cells.
Company Closed or Exit Year